Tags

Type your tag names separated by a space and hit enter

LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
Eur Rev Med Pharmacol Sci 2018; 22(22):7788-7797ER

Abstract

OBJECTIVE

To elucidate the biological functions of long non-coding RNA (lncRNA) SNHG7 in breast cancer (BC), and its underlying mechanism in the occurrence and progression of BC.

PATIENTS AND METHODS

The expression of SNHG7 in 72 pairs of BC tissues and paracancerous tissues was detected by quantitative Real-time polymerase chain reaction (qRT-PCR). Correlation between SNHG7 expressions with pathological indicators of BC patients was analyzed. Similarly, SNHG7 expression in BC cell lines was determined by qRT-PCR as well. After constructing the small inference RNA of SNHG7, cell proliferation, migration and invasion were determined by cell counting kit-8 (CCK-8), 5-Ethynyl-2'-deoxyuridine (EdU) and transwell assay. MicroRNA-186 expression in BC tissues and cells was accessed. Dual-luciferase reporter gene assay was conducted to verify the binding condition between SNHG7 and microRNA-186.

RESULTS

SNHG7 expression was higher in BC tissues than that of paracancerous tissues. High expression of SNHG7 was positively correlated to tumor stage, lymph node metastasis and distant metastasis, whereas not correlated to age, sex and tumor location of BC. Kaplan-Meier curves revealed that higher expression of SNHG7 is correlated to the worse prognosis of BC patients. SNHG7 was highly expressed in BC cells as well. Knockdown of SNHG7 inhibited proliferative, invasive and migratory abilities of BC cells. QRT-PCR data showed that microRNA-186 is lowly expressed in BC tissues compared with that of paracancerous tissues. MicroRNA-186 was lowly expressed in BC cells as well. Both mRNA and protein levels of microRNA-186 were negatively correlated to SNHG7 in BC tissues. Finally, the dual-luciferase reporter gene assay demonstrated that SNHG7 could be directly targeted by microRNA-186.

CONCLUSIONS

SNHG7 is highly expressed in BC, which is correlated to tumor stage, lymph node metastasis and distant metastasis of BC patients. SNHG7 could promote malignant progression of BC by regulating microRNA-186.

Authors+Show Affiliations

Department of Breast Surgery, China-Japan Union Hospital, Jilin University, Changchun, China. jidegangcc@163.com.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

30536320

Citation

Luo, X, et al. "LncRNA SNHG7 Promotes Development of Breast Cancer By Regulating MicroRNA-186." European Review for Medical and Pharmacological Sciences, vol. 22, no. 22, 2018, pp. 7788-7797.
Luo X, Song Y, Tang L, et al. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186. Eur Rev Med Pharmacol Sci. 2018;22(22):7788-7797.
Luo, X., Song, Y., Tang, L., Sun, D. H., & Ji, D. G. (2018). LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186. European Review for Medical and Pharmacological Sciences, 22(22), pp. 7788-7797. doi:10.26355/eurrev_201811_16403.
Luo X, et al. LncRNA SNHG7 Promotes Development of Breast Cancer By Regulating MicroRNA-186. Eur Rev Med Pharmacol Sci. 2018;22(22):7788-7797. PubMed PMID: 30536320.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186. AU - Luo,X, AU - Song,Y, AU - Tang,L, AU - Sun,D-H, AU - Ji,D-G, PY - 2018/12/12/entrez PY - 2018/12/12/pubmed PY - 2018/12/12/medline SP - 7788 EP - 7797 JF - European review for medical and pharmacological sciences JO - Eur Rev Med Pharmacol Sci VL - 22 IS - 22 N2 - OBJECTIVE: To elucidate the biological functions of long non-coding RNA (lncRNA) SNHG7 in breast cancer (BC), and its underlying mechanism in the occurrence and progression of BC. PATIENTS AND METHODS: The expression of SNHG7 in 72 pairs of BC tissues and paracancerous tissues was detected by quantitative Real-time polymerase chain reaction (qRT-PCR). Correlation between SNHG7 expressions with pathological indicators of BC patients was analyzed. Similarly, SNHG7 expression in BC cell lines was determined by qRT-PCR as well. After constructing the small inference RNA of SNHG7, cell proliferation, migration and invasion were determined by cell counting kit-8 (CCK-8), 5-Ethynyl-2'-deoxyuridine (EdU) and transwell assay. MicroRNA-186 expression in BC tissues and cells was accessed. Dual-luciferase reporter gene assay was conducted to verify the binding condition between SNHG7 and microRNA-186. RESULTS: SNHG7 expression was higher in BC tissues than that of paracancerous tissues. High expression of SNHG7 was positively correlated to tumor stage, lymph node metastasis and distant metastasis, whereas not correlated to age, sex and tumor location of BC. Kaplan-Meier curves revealed that higher expression of SNHG7 is correlated to the worse prognosis of BC patients. SNHG7 was highly expressed in BC cells as well. Knockdown of SNHG7 inhibited proliferative, invasive and migratory abilities of BC cells. QRT-PCR data showed that microRNA-186 is lowly expressed in BC tissues compared with that of paracancerous tissues. MicroRNA-186 was lowly expressed in BC cells as well. Both mRNA and protein levels of microRNA-186 were negatively correlated to SNHG7 in BC tissues. Finally, the dual-luciferase reporter gene assay demonstrated that SNHG7 could be directly targeted by microRNA-186. CONCLUSIONS: SNHG7 is highly expressed in BC, which is correlated to tumor stage, lymph node metastasis and distant metastasis of BC patients. SNHG7 could promote malignant progression of BC by regulating microRNA-186. SN - 2284-0729 UR - https://www.unboundmedicine.com/medline/citation/30536320/LncRNA_SNHG7_promotes_development_of_breast_cancer_by_regulating_microRNA_186_ L2 - https://www.europeanreview.org/article/16403 DB - PRIME DP - Unbound Medicine ER -